BlackRock Fund Advisors recently announced the acquisition of new stake in Marathon Oil Corporation (NYSE:MRO). The institutional investor has increased its shareholding in the Energy company by 0.00% to 32.42 million shares with purchase of 944.0 shares. This fresh investment now brings its stake to 5.54% valued currently at $783.25 million. In addition, Invesco Advisers, Inc. raised its holdings by 8.88 million to 18.05 million shares. And Hotchkis & Wiley Capital Manageme has lifted its position by 6.44% or 0.94 million shares – to 15.59 million shares.
Currently, there are 633.00M common shares owned by the public and among those 582.84M shares have been available to trade.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Insiders at the company have transacted a total of 42 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 18 of these insider trades were purchases, accounting for 560,771 shares. Insider sales of the common stock occurred on 24 occasions, with total insider shares sold totaling 776,476 shares.
The top 3 mutual fund holders in Marathon Oil Corporation are Vanguard Total Stock Market ETF, Vanguard 500 Index Fund, and SPDR Series – Energy Select Secto. Vanguard Total Stock Market ETF owns 18.31 million shares of the company’s stock, all valued at over $442.34 million. The company sold -0.68 million shares recently to bring their total holdings to about 3.13% of the shares outstanding. Vanguard 500 Index Fund sold -0.47 million shares to see its total holdings shrink to 14.29 million shares valued at over $345.28 million and representing 2.44% of the shares outstanding. SPDR Series – Energy Select Secto bought 56372.0 shares to bring its total holdings to over 14.21 million shares at a value of $343.32 million. SPDR Series – Energy Select Secto now owns shares totaling to 2.43% of the shares outstanding.
However, the script later moved the day high at 23.25, up 0.35%. The company’s stock has a 5-day price change of 4.22% and -17.46% over the past three months. MRO shares are trading -3.93% year to date (YTD), with the 12-month market performance down to -16.69% lower. It has a 12-month low price of $20.57 and touched a high of $29.56 over the same period. MRO has an average intraday trading volume of 9.65 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -0.65%, -4.18%, and -6.73% respectively.
Institutional ownership of Marathon Oil Corporation (NYSE: MRO) shares accounts for 78.63% of the company’s 633.00M shares outstanding. Mutual fund holders own 34.28%, while other institutional holders and individual stakeholders account for 44.76% and 1.12% respectively.
It has a market capitalization of $13.58B and a beta (3y monthly) value of 2.22. The stock’s trailing 12-month PE ratio is 8.58, while the earnings-per-share (ttm) stands at $2.70. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.23% over the week and 2.22% over the month.
Analysts forecast that Marathon Oil Corporation (MRO) will achieve an EPS of $0.64 for the current quarter, $0.61 for the next quarter and $2.89 for 2024. The lowest estimate earnings-per-share for the quarter is $0.57 while analysts give the company a high EPS estimate of $0.73. Comparatively, EPS for the current quarter was $0.88 a year ago. Earnings per share for the fiscal year are expected to decrease by -42.61%, and 8.63% over the next financial year.
Looking at the support for the MRO, a number of firms have released research notes about the stock. Morgan Stanley stated their Equal-Weight rating for the stock in a research note on December 11, 2023, with the firm’s price target at $27-$25.
